America’s Cup


The 2013 California Biotech CEO Conference is produced by CEOs exclusively for CEOs. The most influential leaders in the life sciences band together for a high level of discussion and debate in a collegial atmosphere.

September 8, 2013
12:00PM – 3:00PM Opening Reception & 34th America’s Cup Match
September 9, 2013
8:00AM – 8:30AM Registration and Networking Breakfast
8:30AM – 9:30AM Opening Keynote | Bi-Coastal Perspective

Keynote Speaker

George Scangos
Biogen Idec

9:30AM – 10:30AM Increasing the Competitiveness of California
A roundtable discussion of strengths and weaknesses and how we can improve our clusters


Paul Hastings
Chief Executive Officer, OncoMed Pharmaceuticals, Inc.


Martin Babler
CEO, Principia BioPharma, Inc.

Dan Bradbury
Managing Member, BioBrit, LLC

S. Claiborne Johnston, M.D., Ph.D.
Director, Clinical and Translational Science Institute, Associate Vice Chancellor of Research, UCSF

John Maraganore, Ph.D.
CEO, Alnylam Pharmaceuticals, Inc.

John Mendlein
Executive Chairman and CEO, aTyr Pharma

10:30AM – 11:30AM Funding Companies Today
A roundtable discussion of innovative financial models, what investors are looking for, recent rounds of financing and what made them successful, recent and prospective IPOs, exit strategies


Kleanthis G. Xanthopoulos, Ph.D.
President and Chief Executive Officer, Regulus Therapeutics, Inc.


Rahul Chaudhary
Leerink Swann LLC

Susan M. Molineaux, Ph.D.
President and CEO, Calithera Biosciences, Inc.

Mike Powell, Ph.D.
General Partner, Sofinnova Ventures, Inc.

Mark Robinson
Partner, Centerview Partners

11:30AM – 12:15PM Networking Luncheon
12:15PM – 1:30PM Luncheon Fireside Chat | Building a Company Today


Paul Hastings
Chief Executive Officer, OncoMed Pharmaceuticals, Inc.


Jean-Jacques Bienaimé
CEO, BioMarin Pharmaceutical, Inc.

David E.I. Pyott, CBE
Chairman of the Board, President and Chief Executive Officer, Allergan, Inc.

Tony Coles, MD
Chairman and Chief Executive Officer, Onyx Pharmaceuticals, Inc.

Mark Stevenson
President and Chief Operating Officer, Life Technologies

1:30PM – 2:30PM Paying for Innovation
A roundtable discussion of decision making process by key payers and where disruptive innovations in medicine fit in that process


James C. Greenwood
President and Chief Executive Officer, Biotechnology Industry Organization


Jonathan S. Leff
Partner, Deerfield

Roger Longman
Chief Executive Officer, Real Endpoints LLC

Kimberly J. Popovits
Chairman of the Board, CEO & President, Genomic Health

David M. Stack
President, CEO, Pacira Pharmaceuticals, Inc.

2:30PM – 4:00PM Dessert Reception and Networking
Honoring the first generation of biotech leaders